StockData
Medtronic plc logo

Medtronic plc (MDT) stock

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/301% above fair value
$100.61−0.11 (-0.11%)

Close on Nov 19, 2026Market cap $128.69BP/E 24.7Yield 2.82%

Medtronic free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Medtronic's free cash flow for the twelve months ending Jul 31, 2026 was $6.13B, up 15.6% year over year. For fiscal 2026 it was $5.43B, up 4.6% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $6.02B in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Apr 24, 2026$5.43B+4.6%
FY2025Apr 25, 2025$5.19B-0.3%
FY2024Apr 26, 2024$5.20B+13.5%
FY2023Apr 28, 2023$4.58B-23.4%
FY2022Apr 29, 2022$5.98B+22.4%
FY2021Apr 30, 2021$4.89B-18.9%
FY2020Apr 24, 2020$6.02B+2.5%
FY2019Apr 26, 2019$5.87B+62.4%
FY2018Apr 27, 2018$3.62B-35.7%
FY2017Apr 28, 2017$5.63B+34.9%
FY2016Apr 29, 2016$4.17B-3.7%
FY2015Apr 24, 2015$4.33B-5.1%
FY2014Apr 25, 2014$4.56B+1.7%
FY2013Apr 26, 2013$4.49B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$1.29B+120.9%
Q4 FY2026CQ1 2026Apr 24, 2026$2.09B+0.8%
Q3 FY2026CQ4 2025Jan 23, 2026$2.30B+9.7%
Q2 FY2026CQ3 2025Oct 24, 2025$457.00M-17.5%
Q1 FY2026CQ2 2025Jul 25, 2025$584.00M+25.3%
Q4 FY2025CQ1 2025Apr 25, 2025$2.07B-12.0%
Q3 FY2025CQ4 2024Jan 24, 2025$2.10B-1.5%
Q2 FY2025CQ3 2024Oct 25, 2024$554.00M+177.0%
Q1 FY2025CQ2 2024Jul 26, 2024$466.00M-10.6%
Q4 FY2024CQ1 2024Apr 26, 2024$2.35B+12.9%
Q3 FY2024CQ4 2023Jan 26, 2024$2.13B+71.3%
Q2 FY2024CQ3 2023Oct 27, 2023$200.00M-66.6%
Q1 FY2024CQ2 2023Jul 28, 2023$521.00M-20.7%
Q4 FY2023CQ1 2023Apr 28, 2023$2.08B+24.8%
Q3 FY2023CQ4 2022Jan 27, 2023$1.24B-34.6%
Q2 FY2023CQ3 2022Oct 28, 2022$599.00M-60.0%
Q1 FY2023CQ2 2022Jul 29, 2022$657.00M-28.1%
Q4 FY2022CQ1 2022Apr 29, 2022$1.67B+21.9%
Q3 FY2022CQ4 2021Jan 28, 2022$1.90B-4.8%
Q2 FY2022CQ3 2021Oct 29, 2021$1.50B-5.2%
Q1 FY2022CQ2 2021Jul 30, 2021$914.00M–
Q4 FY2021CQ1 2021Apr 30, 2021$1.37B+22.8%
Q3 FY2021CQ4 2020Jan 29, 2021$1.99B-5.7%
Q2 FY2021CQ3 2020Oct 30, 2020$1.58B-0.3%
Q1 FY2021CQ2 2020Jul 31, 2020-$56.00M-104.6%
Q4 FY2020CQ1 2020Apr 24, 2020$1.11B-36.4%
Q3 FY2020CQ4 2019Jan 24, 2020$2.11B+20.6%
Q2 FY2020CQ3 2019Oct 25, 2019$1.58B+65.5%
Q1 FY2020CQ2 2019Jul 26, 2019$1.21B-14.3%
Q4 FY2019CQ1 2019Apr 26, 2019$1.75B+134.9%
Q3 FY2019CQ4 2018Jan 25, 2019$1.75B+0.2%
Q2 FY2019CQ3 2018Oct 26, 2018$957.00M+44.8%
Q1 FY2019CQ2 2018Jul 27, 2018$1.41B+207.4%
Q4 FY2018CQ1 2018Apr 27, 2018$746.00M-48.3%
Q3 FY2018CQ4 2017Jan 26, 2018$1.75B-0.5%
Q2 FY2018CQ3 2017Oct 27, 2017$661.00M-45.1%
Q1 FY2018CQ2 2017Jul 28, 2017$459.00M–
Q4 FY2017CQ1 2017Apr 28, 2017$1.44B–
Q3 FY2017CQ4 2016Jan 27, 2017$1.76B–
Q2 FY2017CQ3 2016Oct 28, 2016$1.20B–

More Medtronic figures

See a number that looks wrong?